Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alternate-day versus daily budesonide/formoterol maintenance therapy in children with asthma
ChiCTR1800017421Phase 4Not yet recruiting
- Sponsor
- The Affiliated Hospital of Guangdong Medical University
- Start
- Oct 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of budesonide and formoterol in asthma (2 arms), sponsored by The Affiliated Hospital of Guangdong Medical University. Primary endpoint: Time and number of short-acting beta agonist usage. Planned start Oct 2018; status: not yet recruiting.
02
Drugs
budesonideformoterol
03
Conditions
asthma
Beyond the preview
Go deeper on ChiCTR1800017421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800017421.